The role of ATP6V0D2 in breast cancer: associations with prognosis, immune characteristics, and TNBC progression
ATP6V0D2 acts as a promising indicator for both diagnosis and prediction of outcomes in breast cancer and could potentially be a novel therapeutic target for BRCA.
Authors
- Quanle Wang
- Bin Xu (ORCID: https://orcid.org/0000-0002-3389-3242)
- Haibo Ji (ORCID: https://orcid.org/0000-0003-0495-3311)
- Zhenchuan Song (ORCID: https://orcid.org/0000-0003-3674-1946)
- Lixian Yang (ORCID: https://orcid.org/0000-0002-2396-6030)
- Jingyu Zhang (ORCID: https://orcid.org/0000-0002-9219-8928)
- Xiaohan Wang (ORCID: https://orcid.org/0000-0003-2608-0718)
- Shuo Liu (ORCID: https://orcid.org/0000-0001-9236-6912)
- Xiaolong Li
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Xingtai People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3389/fonc.2024.1511810
- Citations
- 2
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.90